State of Wyoming’s Apellis Pharmaceuticals APLS Stock Holding History

State of Wyoming’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,288	Closed	-$51.8K	–	1895
2026 Q1	$51.8K	Buy	+1,288	New	+$27.8K	0.01%	1532
2022 Q3	–	Sell	-150	Closed	-$7K	–	1525
2022 Q2	$7K	Buy	+150	New	+$6.84K	﹤0.01%	1681
2021 Q4	–	Sell	-276	Closed	-$9K	–	1859
2021 Q3	$9K	Sell	276 -469	-63%	-$26.4K	0.01%	1038
2021 Q2	$47K	Buy	745 +709	+1,969%	+$36.6K	0.03%	762
2021 Q1	$2K	Buy	+36	New	+$1.7K	﹤0.01%	465

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State of Wyoming's APLS Position: Q2 2026 in Review

State of Wyoming sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 1,288 shares — an estimated $51.8K sold.

State of Wyoming first reported a position in APLS in Q1 2021 and held it in 5 quarters. The position peaked at $51.8K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

State of Wyoming reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
State of Wyoming sold 1,288 Apellis Pharmaceuticals shares in Q2 2026, an estimated $51.8K.
State of Wyoming first reported a position in Apellis Pharmaceuticals in Q1 2021 and held it in 5 quarters.
State of Wyoming's Apellis Pharmaceuticals position peaked at $51.8K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.